-
Menopause: The Journal of The Menopause Society Volume 31, 2024: AUTHOR INDEX. Menopause (IF 2.8) Pub Date : 2024-12-01
-
2024 Annual Meeting of The Menopause Society September 11-14, 2024, Chicago, IL. Menopause (IF 2.8) Pub Date : 2024-12-01
-
Association of the number of pregnancies and births with cognitive performance in older postmenopausal women: a cross-sectional study. Menopause (IF 2.8) Pub Date : 2024-12-01 Yue Zhao,Kaixin Li,Junge Peng,Jiang Xiao,Mengying Zhang,Hongfei Mo,Guirong Wang,Yan Li
OBJECTIVE Cognitive impairment in the elderly is a serious public health problem. However, the effect of the number of pregnancies and births in the early years of life on cognitive function in postmenopausal women remains controversial. This study aims to investigate the relationship between these two factors. METHODS We used the National Health and Nutrition Examination Survey 2011-2014 data on women
-
Cinnamon potential in alleviating early postmenopause symptoms: a randomized clinical trial. Menopause (IF 2.8) Pub Date : 2024-12-01 Mansoureh Refaei,Zahra Karami,Farideh Kazemi,Shirin Moradkhani,Seyedeh Zahra Masoumi,Ensieh Jenabi,Mobina Jafari
OBJECTIVE Menopause is a substantial physical, mental, and emotional transition in a woman's life. Most women suffer symptoms during menopause, impacting their quality of life for a decade or more. This study aimed to determine the effect of cinnamon on the severity of postmenopause symptoms. METHODS A randomized, triple-blind, parallel clinical trial was conducted on 60 postmenopausal women in the
-
The course of depressive symptoms over midlife. Menopause (IF 2.8) Pub Date : 2024-12-01 Lydia Brown,Martha Hickey
-
Claudio N Soares, MD, PhD, FRCPC, MBA, CPTR 2024-2025 President, The Menopause Society. Menopause (IF 2.8) Pub Date : 2024-12-01
-
Natural menopause timing and menopause symptoms among lesbian, bisexual, and heterosexual women in the Nurses' Health Study II. Menopause (IF 2.8) Pub Date : 2024-12-01 Nicole A VanKim,Brittany M Charlton,Isa Berzansky,Nicole D Fields,Brian W Whitcomb,Susan E Hankinson,Lynnette Leidy Sievert,Elizabeth R Bertone-Johnson
OBJECTIVE This study aimed to examine sexual orientation differences in natural menopause timing and symptoms between lesbian and bisexual women compared with heterosexual women. METHODS We used longitudinal questionnaire data (1989-2015) from 92,314 women (858 lesbian, 375 bisexual) in the Nurses' Health Study II cohort. Women were 24-44 yr old at baseline and biennially reported their menopause status
-
Trajectories of depressive symptoms in a population-based cohort of Black and White women from late reproductive age through the menopause transition: a 30-year analysis. Menopause (IF 2.8) Pub Date : 2024-12-01 Diana A Chirinos,Zhe Yin,Pamela J Schreiner,Duke Appiah,Melissa F Wellons,Cora E Lewis,Heather G Huddleston,Catherine Kim
OBJECTIVE The aim of this study was to examine how depressive symptoms change in midlife and across the menopause transition. METHODS We conducted a secondary analysis of data from a prospective population-based cohort, the Coronary Artery Risk Development in Young Adults study. We included women (n = 2,160) with ≥3 responses to the Center for Epidemiologic Studies Depression Scale (CES-D) beginning
-
The need for biopsychosocial menopause care: a narrative review. Menopause (IF 2.8) Pub Date : 2024-10-29 Subhadra Evans,Leesa Van Niekerk,Liliana Orellana,Melissa O'Shea,Marilla I Druitt,Sara Jones,Sarah Corrigan,Campbell Heggen,Zuleika Arashiro,Rodney Baber,Lata Satyen,Dave Skvarc,Antonina Mikocka-Walus
IMPORTANCE AND OBJECTIVE Menopause is a reproductive transition affecting half the world's population. Stigma and limited availability of evidence-based treatments that support biopsychosocial well-being mean that this life stage is often associated with challenging symptoms and reduced quality of life (QoL). The aim of this review was to examine the extent literature on psychological and mind-body
-
The association between age at natural menopause and risk of asthma among postmenopausal women from the Canadian Longitudinal Study on Aging. Menopause (IF 2.8) Pub Date : 2024-10-29 Durmalouk Kesibi,Michael Rotondi,Heather Edgell,Hala Tamim
OBJECTIVE This study aimed to investigate the association between age at natural menopause and incidence of asthma among postmenopausal Canadian women. METHODS Women between the ages of 45-85 yr were followed for a 10-yr period. Analysis was restricted to naturally postmenopausal women who are nonsmokers and did not have asthma prior to menopause. Age at natural menopause was examined using the following
-
Multimorbidity in postmenopausal women: a new health challenge. Menopause (IF 2.8) Pub Date : 2024-10-01 James H Liu
-
Addressing menopause symptoms in the primary care setting: opportunity to bridge care delivery gaps. Menopause (IF 2.8) Pub Date : 2024-10-01 Mackenzie L Bevry,Emily R Stogdill,Catherine M Lea,Kathryn R Taylor,Anna M Lovaas,Kaitlyn J Bailey,Kristin C Mara,Ross A Dierkhising,Rajeev Chaudhry,Stephanie S Faubion,Ekta Kapoor
OBJECTIVE Menopause symptoms affect quality of life and financial well-being but are often unaddressed in primary care clinics. Therefore, we evaluated the extent of menopause symptom documentation in electronic health records (EHRs) by primary health care professionals. METHODS We retrospectively reviewed adult women who reported moderate or higher vasomotor symptoms on a Mayo Clinic survey conducted
-
Association of insurance type with unmet need for menopause care in Oregon. Menopause (IF 2.8) Pub Date : 2024-10-01 Maria I Rodriguez,Haley Burns,Kaitlin Schrote,Sara Cichowski,Karen Adams
OBJECTIVE To determine unmet need for menopause care in Oregon and evaluate if insurance type is associated with receipt of care. METHODS We conducted a cross-sectional survey of patients using an Oregon Listserv. Our primary outcome was use of medication for the treatment of moderate or severe symptoms of menopause. We used the Menopause Rating Scale to evaluate respondents' symptoms: 0-4 none or
-
Substance use and menopausal symptoms among people with and without HIV in the US, 2008-2020. Menopause (IF 2.8) Pub Date : 2024-10-01 Andrea K Knittel,Brooke W Bullington,Andrew Edmonds,Lisa Rahangdale,Genevieve Neal-Perry,Catalina Ramirez,Deborah Konkle-Parker,Deborah L Jones,Caitlin A Moran,Elizabeth F Topper,Helen Cejtin,Dominika Seidman,Seble G Kasseye,Tracey E Wilson,Anjali Sharma,Adaora A Adimora
OBJECTIVE The aim of the study is to assess associations between substance use and menopausal symptoms among US people living with and without HIV in a longitudinal cohort. METHODS We analyzed self-reported menopausal symptoms and substance use from biannual Women's Interagency HIV Study (WIHS) visits from 2008-2020. Substance use since the last visit or lifetime cumulative use included tobacco, alcohol
-
PTSD in midlife women: when deconstructing improves screening and influences care. Menopause (IF 2.8) Pub Date : 2024-10-01 Claudio N Soares
-
The effects of motivational interviewing on sexual quality of life and sexual self-efficacy in postmenopausal women with sexual dysfunction. Menopause (IF 2.8) Pub Date : 2024-10-01 Hülya Kamalak,Yeşim Aksoy Derya
OBJECTIVE This study was conducted to determine the effects of motivational interviewing on sexual quality of life and sexual self-efficacy in postmenopausal women with sexual dysfunction. METHODS This randomized controlled study was conducted with 164 postmenopausal women with sexual dysfunction who presented to the gynecology outpatient clinic of a university hospital in Kahramanmaras, Türkiye (82
-
Survey of patient experience and management of vasomotor symptoms due to menopause from the PatientsLikeMe community. Menopause (IF 2.8) Pub Date : 2024-09-10 Jessica A Shepherd,Aki Shiozawa,Arianne L Schild,Deepshikha Singh,Shayna A Mancuso
OBJECTIVE This study aimed to describe menopause and treatment experiences of women with vasomotor symptoms due to menopause in the United States. METHODS A cross-sectional survey was administered to women 40-65 years of age recruited from PatientsLikeMe, a dedicated online platform for patients. RESULTS A total of 196 women (mean age 55.7 years; 81.2% White) completed the survey and were included
-
The development and evaluation of a fact sheet resource for women managing menopausal-related cognitive complaints. Menopause (IF 2.8) Pub Date : 2024-09-10 Chen Zhu,Shalini Arunogiri,Elizabeth H X Thomas,Qi Li,Jayashri Kulkarni,Caroline Gurvich
OBJECTIVES Cognitive symptoms are frequently reported by women during the menopause transition years. The aim of this research was to codesign and evaluate a fact sheet resource to help women understand and manage cognitive symptoms that may occur during menopause. METHODS This study adopted a codesign approach involving women during the menopause transition years as well as professionals to develop
-
Vaginal microbiota, menopause, and the use of menopausal hormone therapy: a cross-sectional, pilot study in Chinese women. Menopause (IF 2.8) Pub Date : 2024-09-03 Yibing Lan,Bihui Jin,Yue Zhang,Yizhou Huang,Zhou Luo,Chang Su,Jingjing Li,Linjuan Ma,Jianhong Zhou
OBJECTIVE To compare the vaginal microbiota of premenopausal and postmenopausal women and postmenopausal women undergoing menopausal hormone therapy (MHT) and examine the association between vaginal microbiota and genitourinary syndrome of menopause (GSM). METHODS This cross-sectional study classified 94 women aged 40 to 60 years into three groups: premenopausal (Pre, n = 32), postmenopausal (Post
-
Exploring menopausal symptoms, attitudes, and behaviors among menopausal women in China: an online research perspective. Menopause (IF 2.8) Pub Date : 2024-09-03 Yang You,Lin Lin,Qi Yu
OBJECTIVE The number of perimenopausal women in China is rising, but the population's concept of menopausal hormone therapy (MHT) is still relatively outdated. METHODS In this study, we used the Knowledge-Attitude-Practice (KAP) theory and collected online questionnaires from 1,100 women aged 40 to 60 years nationwide to find out their menopausal symptom profiles; to learn about their perceptions,
-
History of infertility and anti-Müllerian hormone levels among participants in the Nurses' Health Study II. Menopause (IF 2.8) Pub Date : 2024-09-03 Leslie V Farland,William J Degnan,Elizabeth R Bertone-Johnson,A Heather Eliassen,Siwen Wang,Audrey J Gaskins,Jorge E Chavarro,Janet W Rich-Edwards,Stacey A Missmer
OBJECTIVES To better understand whether history of infertility is associated with anti-Müllerian hormone (AMH) levels later in life, outside of reproduction. METHODS Among 1,758 premenopausal women in the Nurses' Health Study II with measured AMH, we used multivariable generalized linear models to compare log-transformed plasma AMH for women with a history of infertility compared with fertile women
-
The effects of acupressure, laughter yoga, and a mindfulness-based stress reduction program applied to postmenopausal women for menopause symptoms and quality of life. Menopause (IF 2.8) Pub Date : 2024-09-03 Hacer U Koca,Didem S Kucukkelepce,Gulcin Nacar,Nurdilan S Çetin,Sermin T Taşhan
OBJECTIVE This research was conducted to determine the effects of acupressure, laughter yoga, and a mindfulness-based stress reduction program applied to postmenopausal women for menopause symptoms and quality of life. METHODS A randomized controlled design was used. The study was conducted with a total of 146 women, including 41 acupressure, 31 laughter yoga, 37 mindfulness-based stress reduction
-
Treatment satisfaction, unmet needs, and new treatment expectations for vasomotor symptoms due to menopause: women's and physicians' opinions. Menopause (IF 2.8) Pub Date : 2024-09-01 Barbara J DePree,Aki Shiozawa,Janet Kim,Yao Wang,Hongbo Yang,Shayna Mancuso
OBJECTIVE To assess treatment satisfaction, unmet treatment needs, and new vasomotor symptom (VMS) treatment expectations among women with moderate to severe VMS and physicians treating women with VMS. METHODS This noninterventional, nonrandomized survey included qualitative interviews and quantitative surveys of women and physicians in the US. Participating women had moderate to severe VMS in the
-
Menopause and the workplace: consensus recommendations from The Menopause Society. Menopause (IF 2.8) Pub Date : 2024-09-01
Menopause is a natural life transition experienced by half the world's population. Women aged 50 years and older are the fastest growing demographic group in many countries, making essential contributions to the workforce. Although menopause is a universal and natural life transition, the symptom experience is highly variable among women. Some women may experience few or no symptoms, whereas others
-
Menopause Step-by-Step, a new monthly menopause education feature. Menopause (IF 2.8) Pub Date : 2024-09-01 Cynthia A Stuenkel,Cheryl Cox Kinney,Isaac Schiff
-
Female and male factors that impact on frequency of sexual intercourse in aging couples: a cross-sectional study. Menopause (IF 2.8) Pub Date : 2024-08-27 Janaina Pio,Ana Lucia Valadares,Lúcia Costa Paiva
OBJECTIVES To assess the prevalence and factors associated with dyspareunia and the lack of sexual intercourse in women between 50 and 70 years cohabiting with their partners. METHODS This is a descriptive and exploratory cross-sectional study using the snowball technique with prospective data collection using a structured questionnaire to describe multiple aspects of health and sexuality among 266
-
Prevalence of sarcopenic obesity in women and its association with level of independent physical activity combined with sedentary behavior. Menopause (IF 2.8) Pub Date : 2024-08-27 Elaine Silvia Carvalho,Luís Gustavo Alves Silva,Sérgio Antônio Zullo,Renata Damião
OBJECTIVE This study aimed to determine the prevalence of sarcopenic obesity and its association with the level of physical activity, alone and combined with sedentary behavior. METHODS A cross-sectional study was performed. The sample was composed of 317 women aged between 24 and 59 years. Sarcopenic obesity was determined by the coexistence of sarcopenia (reduced muscle mass and strength) and obesity
-
Neurokinin receptor antagonists as potential nonhormone treatments for vasomotor symptoms. Menopause (IF 2.8) Pub Date : 2024-08-27 Nanette Santoro
Managing menopause symptoms is challenging for women unable or unwilling to take hormone therapy. All nonhormone options thus far have shown less overall efficacy compared with hormone therapy and significant adverse events that limit their use. New science has identified the source of vasomotor symptoms, achieving relief of these bothersome symptoms by directly targeting the neurokinin 3 receptor
-
Systemic inflammation and menopausal symptomatology: insights from postmenopausal women. Menopause (IF 2.8) Pub Date : 2024-08-21 Busra Korpe,Caner Kose,Huseyin Levent Keskin
OBJECTIVE This study aims to investigate the association between systemic inflammation, measured by the systemic immune-inflammatory index (SII), and menopausal symptoms in postmenopausal women. METHODS A cross-sectional study was conducted with 702 postmenopausal women recruited from a tertiary hospital. Participants completed the Menopause Rating Scale (MRS) to assess somatic, psychological, and
-
Unraveling the core and bridge menopausal symptoms of perimenopausal women: a network analysis. Menopause (IF 2.8) Pub Date : 2024-08-21 Tianyu Zhang,Yinglu Wan,Li Geng
OBJECTIVE Perimenopause is the period from the early menopausal transition to 12 months after the final menstrual period. The clustering of menopausal symptoms poses a challenge for perimenopausal management. Core symptoms are targets for interventions that can alleviate other related symptoms. Bridge symptoms are connectors that link related symptom clusters and can improve the effectiveness of interventions
-
Sex differences in all-cause mortality and life span between women with premature menopause and men: propensity score matching analysis. Menopause (IF 2.8) Pub Date : 2024-08-13 Zailing Xing, Russell S Kirby
This study investigated sex differences in all-cause mortality and life span between women undergoing premature menopause and men using propensity score matching analysis.
-
Severe menopausal symptoms linked to cognitive impairment: an exploratory study. Menopause (IF 2.8) Pub Date : 2024-08-13 Andrés Calle, Juan E Blümel, Peter Chedraui, María S Vallejo, Alejandra Belardo, Maribel Dextre, Alejandra Elizalde-Cremonte, Carlos Escalante, María T Espinoza, Gustavo Gómez-Tabares, Álvaro Monterrosa-Castro, Mónica Ñañez, Eliana Ojeda, Claudia Rey, Doris Rodríguez, Marcio A Rodrigues, Carlos Salinas, Konstantinos Tserotas, Sócrates Aedo
To evaluate the association between menopausal symptoms and cognitive decline in postmenopausal women.
-
Dimensions of posttraumatic stress disorder and menopause-related health in midlife women veterans. Menopause (IF 2.8) Pub Date : 2024-08-13 Jordan L Thomas, Anna E Blanken, Alison J Huang, Shira Maguen, Carolyn J Gibson, Jennifer A Sumner
Posttraumatic stress disorder (PTSD) has been linked with menopause symptoms (eg, vasomotor, urinary) and their sequelae (eg, sexual difficulties). However, PTSD is a heterogeneous disorder, and less is known about which aspects may be most associated with menopause-related health.
-
Menopause in adult women with human papillomavirus: health-related quality of life and determinants. Menopause (IF 2.8) Pub Date : 2024-08-05 Javier Calvo-Torres,Javier Rejas,Mar Ramírez-Mena,Carmen González-Granados,Melissa Bradbury,Marta Del Pino,Beatriz Procas,Mar Rubio-Arroyo,Jesús Presa-Lorite,Isabel Gippini,María Fasero,Gabriel Fiol,Pablo Romero,Aaron Cohen,Pluvio J Coronado,
OBJECTIVE Human papillomavirus (HPV) infection and menopause entail a considerable impairment in health-related quality of life (HRQoL). The objective of the present study was to analyze the impact of the menopause status on HRQoL in women with HPV infection. METHODS A cross-sectional, nationwide, multicenter sample of women with HPV infection was conducted throughout clinics of gynecology representative
-
Genitourinary syndrome of menopause: patient-centered research outcomes. Menopause (IF 2.8) Pub Date : 2024-08-05 Nancy Phillips
-
The psychological side of menopause: evidence from the comorbidity network of menopausal, anxiety, and depressive symptoms. Menopause (IF 2.8) Pub Date : 2024-07-30 Jie Wen, Wei Wang, Kexin Liu, Xiaole Sun, Jianghua Zhou, Hongxia Hu, Juyan Liang, Xianmin Bi, Rong Li, Miao Miao
Numerous studies have uncovered a correlation between menopausal, anxiety, and depressive symptoms. How these symptoms interrelate and influence each other, however, remains unclear. This study aimed to identify the associations between menopausal, anxiety, and depressive symptoms using network analysis.
-
Association between reproductive lifespan and multimorbidity among Chinese postmenopausal women. Menopause (IF 2.8) Pub Date : 2024-07-30 Jiao Jiao, Xuehua Feng, Ailing Gong, Yi Yao
Although menopause is considered a risk factor for multimorbidity, few studies have explored the association between reproductive lifespan and multimorbidity. This study aimed to explore the association between reproductive lifespan and multimorbidity in postmenopausal Chinese women.
-
From maca to marijuana: cultural influences on joint pain symptoms and management in urban perimenopausal and early postmenopausal Latinas. Menopause (IF 2.8) Pub Date : 2024-07-30 Yamnia I Cortés, Margaret Altemus, Nancy E Reame
The purpose of this qualitative study was to explore the symptom experience and coping strategies for managing joint pain during the menopause transition in urban Latina women.
-
Dietary choline and betaine intake minimally impacts rate of annualized cognitive performance throughout the menopause transition: data from the Study of Women's Health Across the Nation. Menopause (IF 2.8) Pub Date : 2024-07-30 Alexandra E Cowan-Pyle, Taylor C Wallace, Kevin C Klatt, Margaret Slavin, Regan L Bailey
Dietary choline is associated with lower risk of dementia in older adults, yet this association during mid-life remains unknown. Given that menopause reflects a nutrition-sensitive time point where prevention strategies may mitigate cognitive deficits, we examined the relationship of choline, betaine, and egg intakes (ie, dietary exposures) with cognitive performance in the Study of Women's Health
-
Public awareness and provider counseling regarding postmenopausal bleeding as a symptom of endometrial cancer. Menopause (IF 2.8) Pub Date : 2024-07-30 Meredith K Wise, Alexandra M Schefter, Joshua Brill, Kharmen A Bharucha, Katelyn M Tessier, Carrie A Terrell, Britt K Erickson
Our study aims to understand public knowledge of postmenopausal bleeding as an endometrial cancer symptom and how past provider counseling on postmenopausal bleeding affects knowledge and care-seeking behaviors related to postmenopausal bleeding.
-
Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials. Menopause (IF 2.8) Pub Date : 2024-07-30 Jane L Yang, Emmanuelle Hodara, Intira Sriprasert, Donna Shoupe, Frank Z Stanczyk
Menopause, defined by the cessation of menstrual cycles after 12 months of amenorrhea not due to other causes, is associated with significant hormonal changes, primarily a decrease in estrogen, androgen, and progesterone levels. This review delves into the effects of estrogen deficiency during the perimenopausal transition and postmenopause, integrating the findings of basic science with clinical trials
-
The effect of progressive muscle relaxation exercises on postmenopausal sleep quality and fatigue: a single-blind randomized controlled study. Menopause (IF 2.8) Pub Date : 2024-7-26 Cansu Sucu, Elif Tuğçe Çitil
This single-blind, randomized controlled study aimed to determine the effect of progressive muscle relaxation exercises on sleep quality and fatigue in the postmenopausal period. Progressive muscle relaxation aims to relax the muscles in the body and includes breathing techniques.
-
A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Menopause (IF 2.8) Pub Date : 2024-07-23 Surbhi Agrawal, Zoe LaPier, Shavy Nagpal, Antoinette Oot, Steven Friedman, Erinn M Hade, Lila Nachtigall, Benjamin M Brucker, Christina Escobar
The aim of this study was to compare the efficacy of a non-hormone alternative, vaginal hyaluronic acid (HLA), to a standard-of-care therapy, vaginal estrogen, for the treatment of genitourinary syndrome of menopause (GSM).
-
Development of the Menopause Perception Scale. Menopause (IF 2.8) Pub Date : 2024-07-23 Halime Abay, Esra Altun, Sena Kaplan
How women perceive menopause depends on how well they go through that period of time. However, there is no measure that can be used to assess how women perceive menopause. Therefore, we developed a valid and reliable scale (Menopause Perception Scale [MPS]) to assess how women perceive menopause.
-
The role of cardiorespiratory fitness and body composition in the association between physical activity and menopausal symptoms. Menopause (IF 2.8) Pub Date : 2024-07-23 Matti Hyvärinen, Juha Karvanen, Jari E Karppinen, Laura Karavirta, Hanna-Kaarina Juppi, Tuija H Tammelin, Vuokko Kovanen, Jari Laukkanen, Pauliina Aukee, Sarianna Sipilä, Timo Rantalainen, Eija K Laakkonen
The aim of the study was to conduct exploratory analyses on the role of cardiorespiratory fitness (CRF) and body composition in the association between physical activity and menopausal symptoms.
-
Are clinics not affiliated with a Menopause Society Certified Practitioner more likely to offer guideline-nonconcordant treatment compared to clinics affiliated with a Menopause Society Certified Practitioner? Menopause (IF 2.8) Pub Date : 2024-07-09 Jean M Marino, Elizabeth E Stanley, Hannah Ahrendt, Rachel Pope
To identify clinics in Ohio, Michigan, and Pennsylvania that advertise menopause treatment on their website and evaluate whether clinics not affiliated with a Menopause Society Certified Practitioner (MSCP) are more likely to offer guideline-nonconcordant treatment compared to clinics affiliated with an MSCP.
-
Retrospective text and qualitative analyses of patient experience and management of vasomotor symptoms due to menopause: voices from the PatientsLikeMe community. Menopause (IF 2.8) Pub Date : 2024-07-09 Jessica A Shepherd, Aki Shiozawa, Arianne L Schild, Deepshikha Singh, Shayna A Mancuso
Vasomotor symptoms (VMS) due to menopause cause substantial burden and distress. Some women join online communities to share experiences and treatment outcomes through peer-to-peer interactions. This study describes women's experiences with VMS and symptom management on the PatientsLikeMe online support group.
-
Women's perceptions and experiences with cannabis use in menopause: a qualitative study. Menopause (IF 2.8) Pub Date : 2024-07-09 Katherine Babyn, Maira Quintanilha, Sue Ross, Mark Makowsky, Tony Kiang, Nese Yuksel
Since the legalization of recreational cannabis in 2018, the use of cannabis for medical reasons has increased in Canada. The aim of this study was to explore the experiences and perceptions of midlife women using cannabis for medical purposes coinciding with menopause symptom management.
-
Premature ovarian insufficiency: knowledge, attitudes, and quality of care offered by gynecologists. Menopause (IF 2.8) Pub Date : 2024-07-02 Pedro Henrique Rosa E Silva, Silvia Regina Ferreira, Gabriela Pravatta Rezende, Daniela Angerame Yela, Cristina Laguna Benetti-Pinto
Premature ovarian insufficiency (POI) affects up to 3% of the global female population, influencing metabolic, cardiovascular, and reproductive health. Medical expertise in diagnosis, effects, and treatment strategies, particularly for gynecologists, is crucial for ensuring improved healthcare for women. The objective of this study is to assess the state of medical knowledge regarding the diagnosis
-
Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial. Menopause (IF 2.8) Pub Date : 2024-07-02 Chiara Mf Dell'Utri, Elisabetta Manzoni, Irene Bonfanti, Francesca Marrocco, Giussy Barbara, Paola Pifarotti, Francesca Chiaffarino
To compare patient satisfaction rate in postmenopausal women who chose dynamic quadripolar radiofrequency or topical estrogens as their preferred treatment for genitourinary syndrome of menopause.
-
Menopausal knowledge and attitudes of women during the perimenopausal period. Menopause (IF 2.8) Pub Date : 2024-07-02 Mukaddes Turan Miral, Tugba Bayraktar
This study aims to determine the relationship between knowledge and attitudes about menopause among women in the perimenopausal period.
-
Age at natural menopause and its associated characteristics among Brazilian women: cross-sectional results from ELSI-Brazil. Menopause (IF 2.8) Pub Date : 2024-07-02 Nair Tavares Milhem Ygnatios, Juliana Vaz de Melo Mambrini, Juliana Lustosa Torres, Larissa Mendes Dias Detomi, Luciana de Souza Braga, Maria Fernanda Lima-Costa, Bruno de Souza Moreira
This study aimed to determine the median age at natural menopause and analyze lifestyle, anthropometric, and dietary characteristics associated with the age at natural menopause among Brazilian women.
-
Controlling Nutritional Status score and postmenopausal osteoporosis: ERRATUM. Menopause (IF 2.8) Pub Date : 2024-07-01
-
High-density lipoprotein (HDL) and subclinical atherosclerosis in midlife women: new insights into HDL biology from SWAN. Menopause (IF 2.8) Pub Date : 2024-07-01 Zareen Farukhi,JoAnn E Manson
-
Sleep disturbance associated with the menopause. Menopause (IF 2.8) Pub Date : 2024-06-25 Pauline M Maki, Nick Panay, James A Simon
Sleep disturbance is one of the most common and debilitating symptoms experienced by women during the menopause transition. However, there are currently no therapies specifically approved for sleep disturbance associated with the menopause. Here, we consider how to characterize sleep disturbance associated with the menopause and discuss its etiology, including the latest advances in our understanding
-
Arterial stiffness assessment by pulse wave velocity in postmenopausal women: comparison between noninvasive devices. Menopause (IF 2.8) Pub Date : 2024-06-25 Lucimere Bohn, Jessica Rial-Vázquez, Iván Nine, María Rúa-Alonso, Juan Fariñas, Manuel Avelino Giráldez-García, Jorge Mota, Eliseo Iglesias-Soler
This study aimed to ascertain the accuracy of measure arterial stiffness using the HUAWEI GT 3 Pro smartwatch and pOpmètre device against the SphygmoCor (algorithms: intersect tangent and maximum of the second derivate).
-
Menopause and brain fog: how to counsel and treat midlife women. Menopause (IF 2.8) Pub Date : 2024-06-17 Pauline M Maki, Nicole G Jaff
Brain fog, referring to menopause-related subjective cognitive difficulties, is common in midlife women. Longitudinal studies find small but reliable declines in objective memory performance as women transition into perimenopause, and these are not explained by advancing age alone. When memory declines occur, performance levels remain within normal limits for all but a very small number of women. Women's
-
Chronic kidney disease in postmenopausal women is associated with tooth loss. Menopause (IF 2.8) Pub Date : 2024-06-11 Na-Yeong Kim, Ji-Eun Kim, Choong-Ho Choi, Ki-Ho Chung
Menopause is characterized by changes in reproductive hormone levels that can negatively affect bone. Chronic kidney disease (CKD) and tooth loss are also important and common health issues after menopause. This study aimed to evaluate the association between CKD and tooth loss in postmenopausal women.
-
Relationship between menopausal hormone therapy and colorectal cancer: a cohort study utilizing the health insurance database in South Korea (HISK)-II. Menopause (IF 2.8) Pub Date : 2024-06-11 Jin-Sung Yuk, Ji Hyun Noh, Myoung Hwan Kim, Gwan Hee Han, Jungbin Kim, Hyunjin Cho, Geumhee Gwak, Yujin Lee
Many studies have demonstrated that menopausal hormone therapy is associated with a reduced risk for colorectal cancer. This study investigated the relationship between specific hormone therapy regimens and colorectal cancer risk in postmenopausal women in South Korea using national insurance claims data.
-
Quality of life in postmenopausal women and its association with sarcopenia. Menopause (IF 2.8) Pub Date : 2024-06-11 Nikitha Sriramaneni, Chitra Selvan, Nanda Kumar S, Pramila Kalra, Ganavi Y P, Manjunath P R, Altaf Ali Naushad, Sagar Sourabh, Chirag L U
With the menopausal transition, there is a decline in estrogen concentration with potential health consequences affecting the quality of life. The loss of muscle mass, strength, and function, known as sarcopenia is common in postmenopausal women. The primary objective of this study is to assess the quality of life in postmenopausal women and its association with sarcopenia.